A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease

Grant

Awarded By

Total Award Amount

  • 101420.00

    • Direct Costs

  • 78015.00

    • Sponsor Award Id

    • Contributor

  • Maria Acosta Lara   Investigator  
  • Maria I. Danila MD, MSc, MSPH   Investigator  
  • Steven Duncan   Principal Investigator  
  • Tejaswini Kulkarni   Investigator  
  • Tracy Luckhardt   Investigator